About KDDF
R&D Pipeline
R&D Commercialization Initiatives
Media Room
Contact Us
KOR
ENG
About KDDF
Greetings
Who We Are
Networks
R&D Pipeline
Pipeline (2021-2030)
Previous Pipeline (2011-2020)
R&D Commercialization Initiatives
Media Room
Photo & Video
Publications
News
Contact Us
R&D Pipeline
R&D Pipeline
Pipeline (2021-2030)
Pipeline (2021-2030)
Previous Pipeline (2011-2020)
Pipeline (2021-2030)
Respiratory - Phase1 (1)
Modality
Indication
Targets
Stage
Company
Project No.
Detail
1
Phase I clinical study of SB17170 for the drug development for idiopathic pulmonary fibrosis
Small molecules
Idiopathic pulmonary fibrosis
HMGB1
Phase 1
SPARK Biopharma
RS-2023-00259223
BACK